Latest & greatest articles for mammography

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on mammography or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on mammography and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for mammography

201. Breast cancer screening with mammography: overview of Swedish randomised trials. (Abstract)

Breast cancer screening with mammography: overview of Swedish randomised trials. Despite encouraging results from screening trials the efficacy of mammography in reducing mortality remains somewhat controversial. Five studies have been done in Sweden. This overview, based on 282,777 women followed for 5-13 years in randomised trials in Malmö, Kopparberg, Ostergötland, Stockholm, and Gothenburg, reveals a 24% (95% confidence interval 13-34%) significant reduction of breast cancer mortality among (...) those invited to mammography screening compared with those not invited. To avoid the potential risk of differential misclassification causes of death were assessed by an independent end-point committee after a blinded review of all fatal breast cancer cases. The mortality reduction was similar, irrespective of the end-point used for evaluation ("breast cancer as underlying cause of death" or "breast cancer present at death"). There was a consistent risk reduction associated with screening in all

1993 Lancet Controlled trial quality: uncertain

202. The value of mammography screening in women under age 50 years

The value of mammography screening in women under age 50 years The value of mammography screening in women under age 50 years The value of mammography screening in women under age 50 years Eddy D M, Hasselblad V, McGivney W, Hendee W Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability (...) of the study and the conclusions drawn. Health technology Mammography, clinical examination. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Women aged 40-49 years. Setting The study was carried out in the USA. Dates to which data relate Price related to 1984. Source of effectiveness data Review of studies. Modelling Epidemiological cohort model (model of survival and disease). Measure of benefits used in the economic analysis Life-years gained. Direct

1988 NHS Economic Evaluation Database.

203. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. (Abstract)

Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. A randomised controlled trial to investigate the efficacy of mass screening with single-view mammography in reducing mortality from breast cancer was started in Sweden in 1977. 162 981 women aged 40 years or more and living in the counties of Kopparberg and Ostergötland were enrolled in the study

1985 Lancet Controlled trial quality: uncertain

204. Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. (Abstract)

Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. Since 1975 four rounds of screening with modern mammography for breast cancer have been carried out among 30 000 Nijmegen women born before 1940. The results up to the end of 1981 shows that the odds ratio of screened vs unscreened subjects among women who died from breast cancer compared with women who did not, was 0.48 (95% confidence interval 0.23-1.00

1984 Lancet Controlled trial quality: uncertain

205. Evaluation of periodic breast cancer screening with mammography. Methodology and early observations. (Abstract)

Evaluation of periodic breast cancer screening with mammography. Methodology and early observations. 5951878 1966 04 09 2016 10 17 0098-7484 195 9 1966 Feb 28 JAMA JAMA Evaluation of periodic breast cancer screening with mammography. Methodology and early observations. 731-8 Shapiro S S Strax P P Venet L L eng Clinical Trial Journal Article Randomized Controlled Trial United States JAMA 7501160 0098-7484 AIM IM Adult Biopsy Breast Neoplasms diagnosis epidemiology Connecticut Female Follow-Up (...) Studies Humans Mammography Mass Screening Mastectomy Middle Aged Mortality New York Prognosis 1966 2 28 1966 2 28 0 1 1966 2 28 0 0 ppublish 5951878

1966 JAMA Controlled trial quality: uncertain